Cargando…
The C2238/αANP Variant Is a Negative Modulator of Both Viability and Function of Coronary Artery Smooth Muscle Cells
BACKGROUND: Abnormalities of vascular smooth muscle cells (VSMCs) contribute to development of vascular disease. Atrial natriuretic peptide (ANP) exerts important effects on VSMCs. A common ANP molecular variant (T2238C/αANP) has recently emerged as a novel vascular risk factor. OBJECTIVES: We aimed...
Autores principales: | Rubattu, Speranza, Marchitti, Simona, Bianchi, Franca, Di Castro, Sara, Stanzione, Rosita, Cotugno, Maria, Bozzao, Cristina, Sciarretta, Sebastiano, Volpe, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234641/ https://www.ncbi.nlm.nih.gov/pubmed/25401746 http://dx.doi.org/10.1371/journal.pone.0113108 |
Ejemplares similares
-
C2238/αANP modulates apolipoprotein E through Egr-1/miR199a in vascular smooth muscle cells in vitro
por: Stanzione, R, et al.
Publicado: (2015) -
The T2238C Human Atrial Natriuretic Peptide Molecular Variant and the Risk of Cardiovascular Diseases
por: Rubattu, Speranza, et al.
Publicado: (2018) -
C2238 ANP gene variant promotes increased platelet aggregation through the activation of Nox2 and the reduction of cAMP
por: Carnevale, Roberto, et al.
Publicado: (2017) -
Pathogenesis of Ischemic Stroke: Role of Epigenetic Mechanisms
por: Stanzione, Rosita, et al.
Publicado: (2020) -
An interplay between UCP2 and ROS protects cells from high-salt-induced injury through autophagy stimulation
por: Forte, Maurizio, et al.
Publicado: (2021)